Publikation
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma
Wissenschaftlicher Artikel/Review - 15.10.2000
Heinzerling Lucie, Urbanek M, Funk J O, Peker S, Bleck O, Neuber K, Burg G, von Den Driesch P, Dummer R